CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 785.5	$ 429.2
Receivables	487.1	316.0
Investments in marketable securities	444.2	716.9
Goodwill	2,659.6	2,648.7
Acquired client relationships (net)	1,863.1	1,876.0
Equity method investments in Affiliates (net)	1,943.8	2,139.5
Fixed assets (net)	66.3	68.5
Other investments	457.0	421.6
Other assets	259.5	264.6
Total assets	8,966.1	8,881.0
Liabilities and Equity
Payables and accrued liabilities	602.5	778.3
Debt	2,536.4	2,535.3
Deferred income tax liability (net)	487.6	464.7
Other liabilities	470.3	461.7
Total liabilities	4,096.8	4,240.0
Commitments and contingencies (Note 8)
Redeemable non-controlling interests	500.9	465.4
Equity:
Common stock ($0.01 par value, 153.0 shares authorized; 58.5 shares issued in 2022 and 2023)	0.6	0.6
Additional paid-in capital	651.9	695.5
Accumulated other comprehensive loss	(161.2)	(203.4)
Retained earnings	5,977.2	5,718.2
Total stockholders' equity before treasury stock	6,468.5	6,210.9
Less: Treasury stock, at cost (22.7 shares in 2022 and 23.1 shares in 2023)	(3,070.5)	(2,980.6)
Total stockholders' equity	3,398.0	3,230.3
Non-controlling interests	970.4	945.3
Total equity	4,368.4	4,175.6
Total liabilities and equity	$ 8,966.1	$ 8,881.0

Accumulated change in equity applicable to the parent entity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

No definition available.